Case report: Clinical and histopathological characteristics of psoriasiform erythema and de novo IL-17A cytokines expression on lesioned skin in atopic dermatitis children treated with dupilumab

Case report: Clinical and histopathological characteristics of psoriasiform erythema and de novo IL-17A cytokines expression on lesioned skin in atopic dermatitis children treated with dupilumab

BackgroundAtopic dermatitis (AD) is a chronic recurrent inflammatory disease, and dupilumab, a human monoclonal antibody, is the firstly approved biological drug for AD. Psoriasiform erythema (PE) during dupilumab treatment in adults has been reported. This study describes the risk of PE in children...

Full description

Bibliographic Details
Main Authors: Kamran Ali, Liming Wu, YunMi Qiu, Menghua Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Medicine
Subjects:
dupilumab
psoriasiform erythema
interlukine-17A
RNA fluorescence In situ hybridization
atopic dermatitis (AD)
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.932766/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.932766/full

Similar Items